article · 2025
Tolerability and efficacy of induction Bacillus Calmette–Guérin for non-muscle invasive bladder cancer
Inability to tolerate BCG occurred in 28% of patients, with 5.9% experiencing discontinuation. Interruptions were short, mostly concerning UTI, and rarely le...
0 citationsDOI: https://doi.org/10.14440/bladder.2024.0051Open access